Otero, R.; Solier-López, A.; Sánchez-López, V.; Oto, J.; Arellano, E.; MarÃn, S.; Jara-Palomares, L.; ElÃas, T.; Asencio, M.I.; Blasco-Esquivias, I.;
et al. Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study). Cancers 2022, 14, 2771.
https://doi.org/10.3390/cancers14112771
AMA Style
Otero R, Solier-López A, Sánchez-López V, Oto J, Arellano E, MarÃn S, Jara-Palomares L, ElÃas T, Asencio MI, Blasco-Esquivias I,
et al. Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study). Cancers. 2022; 14(11):2771.
https://doi.org/10.3390/cancers14112771
Chicago/Turabian Style
Otero, Remedios, Aurora Solier-López, Verónica Sánchez-López, Julia Oto, Elena Arellano, Samira MarÃn, Luis Jara-Palomares, Teresa ElÃas, MarÃa Isabel Asencio, Isabel Blasco-Esquivias,
and et al. 2022. "Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study)" Cancers 14, no. 11: 2771.
https://doi.org/10.3390/cancers14112771
APA Style
Otero, R., Solier-López, A., Sánchez-López, V., Oto, J., Arellano, E., MarÃn, S., Jara-Palomares, L., ElÃas, T., Asencio, M. I., Blasco-Esquivias, I., RodrÃguez de la Borbolla, M., Sánchez-DÃaz, J. M., Real-DomÃnguez, M., GarcÃa-Cabrera, E., RodrÃguez-Martorell, F. J., & Medina, P.
(2022). Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study). Cancers, 14(11), 2771.
https://doi.org/10.3390/cancers14112771
